To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Arlington acquires majority stake in Everest Clinical Research
Arlington Capital Partners has made a majority investment in Everest Clinical Research Corp, a Toronto-based provider of clinical research services.
